Loading...
XBKK
KISS
Market cap41mUSD
Nov 12, Last price  
2.36THB
Name

Rojukis International PCL

Chart & Performance

D1W1MN
XBKK:KISS chart
P/E
8.34
P/S
1.14
EPS
0.28
Div Yield, %
8.05%
Shrs. gr., 5y
-0.81%
Rev. gr., 5y
4.58%
Revenues
1.21b
+3.21%
433,331,499592,531,972863,181,9531,138,014,047964,983,587772,267,122932,328,520964,768,4741,169,455,4291,206,994,256
Net income
165m
+3.58%
64,515,94060,454,926105,844,392190,138,958167,992,157118,573,154123,708,283131,400,578159,736,735165,456,945
CFO
205m
+44.76%
00-18,559,736200,780,815268,746,176177,951,27585,538,26720,348,302141,481,908204,814,147
Dividend
Apr 30, 20260.1 THB/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Rojukiss International Public Company Limited, headquartered in Huai Khwang, Thailand, is a prominent distributor of various beauty and wellness products. The company supplies an array of items, including skincare formulations, cosmetic goods, and dietary supplements, to consumers across Thailand, Hong Kong, Indonesia, and other global markets. Additionally, the firm engages in the wholesale trade of pharmaceutical and medical supplies. Its extensive product portfolio is marketed under brand names such as Rojukiss, PHDerma, Best Korea, Wonder Herb, and Sis2Sis. The enterprise, which began operations in 2007, was formerly known as Agenz Company Limited.
IPO date
Feb 19, 2021
Employees
Domiciled in
TH
Incorporated in
TH

Valuation

Title
THB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT